JPMorgan Chase & Co. started coverage on shares of Phreesia (NYSE:PHR) in a report published on Tuesday morning, BenzingaRatingsTable reports. The firm issued an overweight rating and a $33.00 price objective on the stock.

Several other equities analysts also recently commented on PHR. William Blair assumed coverage on Phreesia in a report on Monday. They set an outperform rating on the stock. Chardan Capital assumed coverage on Phreesia in a report on Tuesday, July 23rd. They set a buy rating and a $33.00 price target on the stock. Wells Fargo & Co assumed coverage on Phreesia in a research report on Monday. They issued an outperform rating and a $23.00 price objective for the company. Finally, Piper Jaffray Companies assumed coverage on Phreesia in a research report on Monday. They issued an overweight rating and a $33.00 price objective for the company. Five investment analysts have rated the stock with a buy rating, Phreesia presently has an average rating of Buy and a consensus target price of $30.50.

Shares of PHR stock opened at $28.66 on Tuesday. Phreesia has a 12 month low of $23.00 and a 12 month high of $29.38.

In other Phreesia news, Director Scott Perricelli sold 743,388 shares of the business’s stock in a transaction that occurred on Monday, July 22nd. The stock was sold at an average price of $18.00, for a total value of $13,380,984.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, major shareholder Ii L.P. Chv sold 335,767 shares of the business’s stock in a transaction that occurred on Monday, July 22nd. The shares were sold at an average price of $18.00, for a total value of $6,043,806.00. The disclosure for this sale can be found here.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process and an integrated payments solution for processing of patient payments.

See Also: What economic reports are most valuable to investors?

Analyst Recommendations for Phreesia (NYSE:PHR)

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.